Anti-CD80 antibody [EPR22183]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(5 Publications)
Rabbit Recombinant Monoclonal CD80 antibody. Suitable for IP, Flow Cyt, ICC/IF and reacts with Human samples. Cited in 5 publications.
View Alternative Names
CD80, CD28LG, CD28LG1, LAB7, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CD80 antibody [EPR22183] (AB225674)
Immunofluorescent analysis of 100% methanol-fixed Raji (human Burkitt's lymphoma cell line) and HUVEC (human umbilical vein endothelial cell line) cells labeling CD80 with ab225674 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous staining in Raji cell line is observed. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).
PBS only control : Used PBS instead of primary antibody, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution dilution.
Negative control : HUVEC (PMID : 15064090).
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-CD80 antibody [EPR22183] (AB225674)
Flow cytometric analysis of HUVEC (human umbilical vein endothelial cell line) (left panel) cells and Raji (human Burkitt's lymphoma cell line)(right panel) cells labeling CD80 with ab225674 at 1/400 (red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077), at 1/2000 dilution was used as the secondary antibody.
Gated on viable cells.
Negative control : HUVEC (PMID : 15064090).
- Flow Cyt
Lab
Flow Cytometry - Anti-CD80 antibody [EPR22183] (AB225674)
Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) (top) or PBMCs treated with CD3/CD28 activation (bottom), with ab225674 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left).
PBMCs were incubated for 30 min on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interactions, followed by the antibody ab225674 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 5.0 μg/ml (1/400)) for 30 min at 22°C . Cells were simultaneously stained with CD4
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/2000 for 30min at 22°C.
Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.
- IP
Unknown
Immunoprecipitation - Anti-CD80 antibody [EPR22183] (AB225674)
CD80 was immunoprecipitated from 0.35 mg of Raji (human Burkitt's lymphoma cell line) whole cell lysate with ab225674 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab225674 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : Raji whole cell lysate 10 μg (Input).
Lane 2 : ab225674 IP in Raji whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab225674 in Raji whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 second.
This blot was developed using a higher sensitivity ECL substrate.
All lanes:
Immunoprecipitation - Anti-CD80 antibody [EPR22183] (ab225674)
Predicted band size: 33 kDa
Observed band size: 60 kDa
false
Related conjugates and formulations (3)
-
Anti-CD80 antibody [EPR22183] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD80 antibody [EPR22183]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD80 antibody [EPR22183]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD80 plays a significant role in the immune system's ability to distinguish between self and non-self. It belongs to the B7 family and participates in the formation of immunological synapses between T cells and antigen-presenting cells. This interaction is essential for triggering T cell proliferation and cytokine production forming a part of the adaptive immune response. CD80's expression increases in response to pathogen recognition enhancing the immune system's efficiency.
Pathways
CD80 is integral to the regulation of T cell-mediated immune responses. It is involved in the CD28 co-stimulatory pathway which is vital for T cell activation and function. In this pathway CD80 interacts with proteins like CD28 and CTLA-4 to modulate immune activation and regulate immune tolerance. The proper function of CD80 within this pathway ensures a balanced immune reaction preventing autoimmunity while allowing effective defense against pathogens.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Journal of experimental & clinical cancer research : CR 44:170 PubMed40462177
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 17:1267-1279 PubMed38434584
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 11:90 PubMed36819570
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:785403 PubMed34899349
2021
Applications
Unspecified application
Species
Unspecified reactive species
Advanced biology 5:e2000428 PubMed33852179
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com